Cargando…

Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies

Despite the significant contributions of immunocompetent mouse models to the development and assessment of cancer immunotherapies, they inadequately represent the genetic and biological complexity of corresponding human cancers. Immunocompromised mice reconstituted with a human immune system (HIS) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bareham, Bethany, Georgakopoulos, Nikitas, Matas-Céspedes, Alba, Curran, Michelle, Saeb-Parsy, Kourosh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423639/ https://www.ncbi.nlm.nih.gov/pubmed/33830275 http://dx.doi.org/10.1007/s00262-021-02897-5

Ejemplares similares

Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy‐induced cytokine release syndrome
por: Matas‐Céspedes, Alba, et al.
Publicado: (2020)

Bioengineering solutions for ureteric disorders: clinical need, challenges and opportunities
por: Kapetanos, Konstantinos, et al.
Publicado: (2022)

Long-term expansion, genomic stability and in vivo safety of adult human pancreas organoids
por: Georgakopoulos, Nikitas, et al.
Publicado: (2020)

Protocol of a randomised controlled, open-label trial of ex vivo normothermic perfusion versus static cold storage in donation after circulatory death renal transplantation
por: Hosgood, Sarah A, et al.
Publicado: (2017)

Protection against renal ischemia–reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ
por: Dare, Anna J., et al.
Publicado: (2015)

Successful Transplantation of Human Kidneys Deemed Untransplantable but Resuscitated by Ex Vivo Normothermic Machine Perfusion
por: Hosgood, S. A., et al.
Publicado: (2016)

Mesothelioma with non-pleural malignancy: a red herring or just an uncommon pairing?
por: Drain, Andrew J, et al.
Publicado: (2006)

Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury
por: Martin, Jack L., et al.
Publicado: (2018)

Immunological considerations and challenges for regenerative cellular therapies
por: Petrus-Reurer, Sandra, et al.
Publicado: (2021)

Distinct microbial and immune niches of the human colon
por: James, Kylie R, et al.
Publicado: (2020)

Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors
por: Lainé, Alexandra, et al.
Publicado: (2023)

Assessment of H(2)S in vivo using the newly developed mitochondria-targeted mass spectrometry probe MitoA
por: Arndt, Sabine, et al.
Publicado: (2017)

Preclinical models of arthritis for studying immunotherapy and immune tolerance
por: Meehan, Gavin R, et al.
Publicado: (2021)

Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens
por: Vidal-Crespo, Anna, et al.
Publicado: (2020)

Phenotypically distinct neutrophils patrol uninfected human and mouse lymph nodes
por: Lok, Laurence S. C., et al.
Publicado: (2019)

Older Adult Substance Use, Support, Health, and Well-Being: Understanding a Complex Picture
por: Bareham, Bethany, et al.
Publicado: (2021)

Mitochondrial metabolism and bioenergetic function in an anoxic isolated adult mouse cardiomyocyte model of in vivo cardiac ischemia-reperfusion injury
por: Gruszczyk, Anja V., et al.
Publicado: (2022)

Tumor hypoxia drives immune suppression and immunotherapy resistance
por: Ai, Midan, et al.
Publicado: (2015)

Preclinical Study of Plasmodium Immunotherapy Combined with Radiotherapy for Solid Tumors
por: Tao, Zhu, et al.
Publicado: (2022)

B Lymphocyte–Derived CCL7 Augments Neutrophil and Monocyte Recruitment, Exacerbating Acute Kidney Injury
por: Inaba, Akimichi, et al.
Publicado: (2020)

Managing older people’s perceptions of alcohol-related risk: a qualitative exploration in Northern English primary care
por: Bareham, Bethany Kate, et al.
Publicado: (2020)

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
por: Xu, Liangliang, et al.
Publicado: (2022)

Multimodality Imaging In Vivo for Preclinical Assessment of Tumor-Targeted Doxorubicin Nanoparticles
por: Hwang, Jae Youn, et al.
Publicado: (2012)

Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies
por: Dholakia, Jhalak, et al.
Publicado: (2021)

Imaging cellular immunotherapies and immune cell biomarkers: from preclinical studies to patients
por: Volpe, Alessia, et al.
Publicado: (2022)

Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model
por: Veinalde, Rūta, et al.
Publicado: (2023)

Health and social care providers’ perspectives of older people’s drinking: a systematic review and thematic synthesis of qualitative studies
por: Bareham, Bethany Kate, et al.
Publicado: (2020)

Factors affecting primary care practitioners’ alcohol-related discussions with older adults: a qualitative study
por: Bareham, Bethany Kate, et al.
Publicado: (2021)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Editorial: Imaging the immune response in inflammatory preclinical in vivo models
por: Erreni, M., et al.
Publicado: (2023)

In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response
por: Sahu, Aditi, et al.
Publicado: (2022)

Drinking in later life: a systematic review and thematic synthesis of qualitative studies exploring older people’s perceptions and experiences
por: Bareham, Bethany Kate, et al.
Publicado: (2019)

How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research
por: De Bruycker, Sven, et al.
Publicado: (2018)

Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer
por: Foy, Susan P, et al.
Publicado: (2014)

In Vivo Murine-Matured Human CD3(+) Cells as a Preclinical Model for T Cell-Based Immunotherapies
por: Haworth, Kevin G., et al.
Publicado: (2017)

Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized mice
por: Matas-Céspedes, Alba, et al.
Publicado: (2023)

Targeting the Innate Immune System as Immunotherapy for Acute Myeloid Leukemia
por: Curran, Emily, et al.
Publicado: (2015)

Patient‐derived preclinical models to develop immunotherapies
por: Seoane, Joan
Publicado: (2023)

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma
por: Lu, Xinjun, et al.
Publicado: (2023)

Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy
por: Vanderstraeten, Anke, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_374i8h9onqojmihmpalifuaheg